RAS Mutational Status Detection in Tissue, Plasma, and Stool Samples for Colorectal Cancer

OBJECTIVE: RAS gene testing on tumor tissue biopsies is required for metastatic colorectal cancer (CRC) patients. However, it is infeasible for patients after curative surgery and repeated biopsy. This study is aimed at evaluating the consistency of RAS genes in patient's plasma, stool, and tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Liuying, Wang, Yuanhe, Zhou, Yang, Dong, Qian, Liu, Yunpeng, Zhang, Jingdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174943/
https://www.ncbi.nlm.nih.gov/pubmed/32351996
http://dx.doi.org/10.1155/2020/5419634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174943/
https://www.ncbi.nlm.nih.gov/pubmed/32351996
http://dx.doi.org/10.1155/2020/5419634

Ejemplares similares